Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vomiting 2Polyps 1Neoplasms 1Nausea 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hypopharyngeal Neoplasms 1Critical Illness 1

Interventions

Dexamethasone 9Calcium Dobesilate 8Aprepitant 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Palonosetron 4Granisetron 4Doxorubicin 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Psychiatric Rehabilitation 3Cyclophosphamide 3auricularum 2Yoga 2Surveys and Questionnaires 2Standard of Care 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Diphenhydramine 2Control Groups 2Acupuncture Therapy 2Acupressure 2salicylhydroxamic acid 1phenazine 1peppermint oil 1dolasetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Vomiting × Metoclopramide × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT01093690 2010-12-02

Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin

Mahidol University

Phase NA Completed
162 enrolled 5 charts

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡